HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toru Nakamura Selected Research

Stomach Neoplasms (Stomach Cancer)

5/2021Initial Results of Laparoscopic Proximal Gastrectomy With Double-tract Reconstruction Using Oblique Jejunogastrostomy Method on the Long-term Outcome of Postoperative Nutritional Status: A Propensity Score-matched Study.
1/2020Jejunal intussusception at the jejunojejunostomy after laparoscopic total gastrectomy: A case report.
1/2020Robot-assisted laparoscopic total gastrectomy for Epstein-Barr virus-associated multiple gastric cancer: A case report.
5/2019Central pancreatic body-preserving pancreatoduodenectomy for pancreatic head cancer following a combined total gastrectomy and distal pancreatectomy: a case report.
9/2017Laparoscopic proximal gastrectomy with oblique jejunogastrostomy.
12/2015Totally laparoscopic gastrectomy for gastric cancer after endoscopic submucosal dissection: a propensity score matching analysis.
11/2013CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toru Nakamura Research Topics

Disease

83Neoplasms (Cancer)
02/2024 - 03/2004
26Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 03/2004
20Adenocarcinoma
02/2024 - 03/2004
16Hepatocellular Carcinoma (Hepatoma)
02/2024 - 05/2004
15Neoplasm Metastasis (Metastasis)
10/2020 - 04/2006
12Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 03/2006
9Klatskin Tumor
01/2024 - 08/2014
9Colonic Neoplasms (Colon Cancer)
03/2016 - 05/2005
8Fibrosis (Cirrhosis)
12/2024 - 03/2006
8Lymphatic Metastasis
12/2023 - 06/2006
8Carcinoma (Carcinomatosis)
06/2022 - 12/2006
7Cholangiocarcinoma
12/2023 - 07/2014
7Wounds and Injuries (Trauma)
02/2022 - 04/2013
7Stomach Neoplasms (Stomach Cancer)
05/2021 - 11/2013
6Inflammation (Inflammations)
02/2018 - 07/2009
5Infections
09/2022 - 01/2002
5Hemorrhage
04/2020 - 11/2005
5Schizophrenia (Dementia Praecox)
01/2017 - 11/2014
5Body Weight (Weight, Body)
11/2016 - 04/2006
4Hypoxia (Hypoxemia)
01/2023 - 06/2012
4Pancreatic Fistula (Pancreatic Fistulas)
01/2023 - 12/2018
4Pain (Aches)
05/2022 - 03/2016
4Margins of Excision
01/2021 - 04/2015
4Carcinogenesis
01/2016 - 03/2004
4Hyperuricemia
01/2013 - 04/2008
3Liver Neoplasms (Liver Cancer)
08/2023 - 03/2012
3Lung Neoplasms (Lung Cancer)
11/2022 - 01/2018
3Liver Failure
06/2022 - 01/2016
3Breast Neoplasms (Breast Cancer)
05/2022 - 01/2005
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 06/2006
3Melanoma (Melanoma, Malignant)
09/2020 - 12/2006
3Ascites
12/2019 - 05/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 03/2009
3Surgical Wound Infection
09/2018 - 08/2010
3Primitive Neuroectodermal Tumors (PNET)
12/2017 - 12/2014
3Non-alcoholic Fatty Liver Disease
11/2013 - 07/2009
2Fatty Liver
03/2024 - 01/2017

Drug/Important Bio-Agent (IBA)

11Biomarkers (Surrogate Marker)IBA
02/2023 - 11/2014
9AntigensIBA
02/2023 - 01/2005
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 04/2006
8Complementary DNA (cDNA)IBA
02/2023 - 03/2004
8Proteins (Proteins, Gene)FDA Link
01/2020 - 04/2006
8ErbB Receptors (EGF Receptor)IBA
07/2012 - 12/2006
6erucylphosphocholineIBA
01/2016 - 03/2006
5Uric Acid (Urate)IBA
12/2014 - 04/2008
5Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2008 - 06/2006
4Carcinoembryonic AntigenIBA
11/2023 - 01/2005
4Tumor Biomarkers (Tumor Markers)IBA
02/2023 - 03/2004
4Fluorouracil (Carac)FDA LinkGeneric
11/2022 - 03/2011
4Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2011 - 12/2006
4Irinotecan (Camptosar)FDA LinkGeneric
05/2008 - 12/2006
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2024 - 01/2002
3Serum AlbuminIBA
11/2023 - 05/2014
3Immune Checkpoint InhibitorsIBA
10/2023 - 09/2020
3LigandsIBA
08/2023 - 02/2008
3Cadherins (E-Cadherin)IBA
03/2023 - 04/2005
3Tyrosine Kinase InhibitorsIBA
01/2023 - 05/2008
3ProdrugsIBA
11/2022 - 03/2011
3Flucytosine (Ancobon)FDA Link
11/2022 - 03/2012
3Cytosine DeaminaseIBA
11/2022 - 03/2012
3Triclosan (pHisoHex)FDA Link
02/2022 - 04/2013
3CarbohydratesIBA
01/2022 - 01/2005
3CytokinesIBA
07/2020 - 04/2010
3Alanine Transaminase (SGPT)IBA
02/2018 - 04/2006
3Peptides (Polypeptides)IBA
12/2017 - 05/2005
3Indicators and Reagents (Reagents)IBA
04/2017 - 03/2015
3pentosidineIBA
01/2017 - 11/2014
3Matrix Metalloproteinases (MMPs)IBA
10/2014 - 07/2007
3Messenger RNA (mRNA)IBA
11/2013 - 05/2004
3Epidermal Growth Factor (EGF)IBA
07/2012 - 12/2006
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2012 - 01/2008
3Transforming Growth Factor alpha (TGF-alpha)IBA
07/2008 - 12/2007
3AEE 788 (AEE788)IBA
01/2008 - 12/2006
3Imatinib Mesylate (Gleevec)FDA Link
01/2008 - 06/2006
2Hydroxyproline (4 Hydroxyproline)IBA
03/2024 - 07/2020
2Amino AcidsFDA Link
03/2024 - 02/2023
2MicroRNAs (MicroRNA)IBA
02/2024 - 11/2013
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2024 - 01/2023
2Histones (Histone)IBA
12/2023 - 11/2013
2lenvatinibIBA
10/2023 - 04/2020
2RNA (Ribonucleic Acid)IBA
10/2023 - 10/2020
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2023 - 01/2008
2AntibodiesIBA
08/2023 - 02/2023

Therapy/Procedure

33Therapeutics
12/2024 - 01/2002
13Drug Therapy (Chemotherapy)
01/2024 - 01/2002
12Pancreatectomy
01/2023 - 03/2014
10Gastrectomy
05/2021 - 12/2015
10Pancreaticoduodenectomy
01/2021 - 06/2014
9Lymph Node Excision (Lymph Node Dissection)
09/2022 - 09/2012
9Hepatectomy
09/2022 - 02/2015
7Transplantation
10/2014 - 03/2006
6Neoadjuvant Therapy
01/2022 - 05/2016
5Sutures (Suture)
02/2022 - 04/2013
5Esophagectomy
09/2021 - 06/2017
4Lasers (Laser)
08/2007 - 03/2004
3Cell Transplantation
03/2024 - 04/2012
3Immunotherapy
10/2023 - 05/2005
3Chemoradiotherapy
06/2019 - 04/2015
2Polypharmacy
02/2024 - 01/2017
2Palliative Care (Palliative Therapy)
02/2024 - 04/2020